Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity
- 24 October 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 285 (3) , 289-297
- https://doi.org/10.1016/0014-2999(95)00422-h
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Molecular pharmacology of the AMPA agonist, (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPANeurochemistry International, 1994
- Excitatory amino acid receptors: A gallery of new targets for pharmacological interventionLife Sciences, 1994
- Pharmacological specificity of
methyl -D -aspartate discrimination in ratsNeuropharmacology, 1993 - NMDA receptor agonists derived from ibotenic acid. Preparation, neuroexcitation and neurotoxicityEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Structure-activity relationships in the development of excitatory ammo acid receptor agonists and competitive antagonistsTrends in Pharmacological Sciences, 1990
- The Excitatory Amino Acid Receptors: Their Classes, Pharmacology, and Distinct Properties in the Function of the Central Nervous SystemAnnual Review of Pharmacology and Toxicology, 1989
- CGS 19755 is a potent and competitive antagonist at NMDA-type receptorsEuropean Journal of Pharmacology, 1988
- Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor AntagonistsScience, 1988
- N-methyl-d-aspartate produces discriminative stimuli in ratsLife Sciences, 1987
- Ibotenic Acid Analogues. Synthesis, Molecular Flexibility, and in Vitro Activity of Agonists and Antagonists at Central Glutamic Acid ReceptorsJournal of Medicinal Chemistry, 1985